皮肤毒性测试市场 - 2018-2028 年全球产业规模、份额、趋势、机会和预测，按测试类型、测试方法类型（体内测试和体外测试）、最终用户、地区、竞争细分

2022年，全球皮肤毒性​​测试市场估值达到18.1亿美元，预计在预测期内将强劲增长，预计复合年增长率（CAGR）为8.17%，预计到2022年将达到28.8亿美元。2028. 皮肤毒性测试是一项综合程序，旨在评估物质对人体皮肤的不利影响。该过程涉及对测试物质进行各种方案，从传统的基于动物的方法到复製人类皮肤特征的创新体外模型。其主要目的是识别皮肤接触可能引起的任何刺激、过敏反应、致敏或全身毒性。皮肤毒性测试领域取得了重大进展，从依赖动物测试转向更先进和人性化的方法。体外模型、3D 皮肤等效物和微流体平台正在彻底改变测试的准确性和效率。

主要市场驱动因素：

• 1.产业特定需求：产业特定需求对全球皮肤毒性​​测试市场的成长有重大影响。皮肤毒性测试对于产品安全评估至关重要，特别是在化妆品、药品、化学物质和消费品等行业。不同行业遵守不同的产品安全和测试法规和指南。例如，化妆品行业必须遵守美国 FDA 或欧洲药品管理局 (EMA) 等机构制定的法规。这些法规通常要求进行彻底的皮肤毒性测试，以确保产品成分的安全。随着监管要求的发展，产业被迫采用先进的测试方法，推动市场成长。化妆品行业高度重视皮肤毒性测试，以确保护肤品、化妆品和个人护理用品不会引起皮肤不良反应。随着消费者对天然和有机产品的需求不断增加，对验证产品安全性进行彻底测试的需求不断增长，从而刺激了对创新皮肤毒性测试方法的需求。在製药领域，皮肤毒性测试对于评估经皮给药系统（例如贴片和乳霜）的安全性至关重要。随着製药公司开发新药物和输送机制，他们需要先进的测试方法来深入了解这些物质如何与皮肤相互作用，从而促进市场成长。涉及化学品的行业，包括工业、农业和家用化学品，必须确保其产品的安全，以保护工人和消费者。皮肤毒性测试对于确定与皮肤暴露相关的潜在风险至关重要。随着工作场所安全和消费者健康意识的增强，这些行业的公司可能会投资更全面的测试方法，从而促进市场成长。

市场概况
预测期	2024-2028
2022 年市场规模	18.1亿美元
2028 年市场规模	28.8亿美元
2023-2028 年复合年增长率	8.17%
成长最快的细分市场	化妆品及个人护理
最大的市场	北美洲

• 2.向非动物测试方法的转变：向非动物测试方法的转变极大地影响了全球皮肤毒性​​测试市场的成长。对动物福利、监管变化和技术进步的担忧正在推动替代测试方法的采用，从而重塑市场的成长轨迹。世界各地的许多监管机构越来越多地提倡甚至强制要求在安全评估中使用非动物测试方法。例如，欧盟的 REACH（化学品註册、评估、授权和限制）法规提倡采用动物试验的替代方法进行化学品安全评估。监管机构认可并认可非动物方法，会激励公司采用这些方法以维持合规性，从而促进市场成长。使用动物进行测试会引发道德问题，并对公司的声誉产生负面影响。随着大众对动物福利意识的增强，消费者和利害关係人可能会青睐采用无残忍检测方法的公司，从而有可能促进市场成长。非动物测试方法，例如体外技术、重建人体皮肤模型和计算建模，在准确性和可靠性方面都得到了提高，使其成为传统动物测试的可行替代方案。随着科学界开发和验证这些方法，寻求更具预测性和更有效率测试的行业倾向于采用它们，从而有助于市场扩张。向非动物测试方法的转变鼓励了毒理学领域的研究和创新，包括新技术和改进模型的开发。优先考虑创新并处于科学进步前沿的行业可能会投资这些方法，从而促进市场成长。
• 3.技术创新：技术创新在影响全球皮肤毒性​​测试市场的成长中发挥关键作用。随着技术的进步提供了更准确、更有效率和更具成本效益的测试方法，产业和监管机构越来越多地采用这些创新来确保产品安全。技术进步促进了复杂的体外测试方法的发展，该方法使用人类细胞、组织和 3D 模型来准确模拟皮肤反应。与传统的动物测试相比，体外测试可以更相关、更可靠地代表人类反应，有助于寻求准确毒性评估的行业采用它。微流体和晶片器官技术使得能够创造出模仿人体器官（包括皮肤）的结构和功能的微型设备。这些模型提供了一个受控环境来研究细胞对物质的反应，提供对毒性的即时洞察，并模拟物质与皮肤的相互作用，帮助危险识别和市场成长。高通量筛选 (HTS) 技术可以同时快速检测多种物质，加快筛选过程并儘早识别潜在危害。各行业可以使用 HTS 来降低成本并缩短上市时间，有助于市场扩张。计算模型和人工智慧（AI）技术能够根据分子结构和相互作用预测皮肤毒性，增强预测能力并减少大量实验室测试的需要，从而促进市场成长。
• 4.公众意识和品牌声誉：公众意识和品牌声誉对全球皮肤毒性​​测试市场的成长有重大影响。随着消费者对产品安全和道德考虑的意识日益增强，以及品牌努力保持良好的声誉，对全面皮肤毒性测试的需求不断增加。在当今具有社会意识的世界中，消费者越来越关注道德实践，包括动物福利和环境影响。优先考虑非动物测试方法并致力于道德产品开发的品牌可能会引起这些消费者的共鸣，从而推动对全面皮肤毒性测试的需求。大众对产品相关潜在健康风险的认知促使消费者要求更安全、更透明的配方。进行彻底的皮肤毒性测试以确保产品安全的品牌可以赢得消费者的信任。透过严格的测试和准确的标籤解决消费者安全问题，品牌可以提高声誉并培养客户忠诚度。

主要市场挑战：

• 1.替代方法的验证：替代方法的验证可能会带来挑战，并可能阻碍全球皮肤毒性​​测试市场的成长。虽然替代方法因其伦理考量和科学进步而受到追捧，但其验证过程可能复杂且耗时。替代方法的验证需要广泛的研究、资料收集以及与已建立的参考方法（通常包括动物测试基准）的比较。这个过程可能非常耗时且耗费资源，从而减慢了这些方法的采用速度，并可能阻碍市场成长。
• 2.标准化问题：皮肤毒性测试缺乏标准化方案可能会导致测试结果不一致且可变，难以比较不同研究或实验室之间的结果。这种不一致会削弱人们对测试方法可靠性的信心并阻碍市场成长。监管机构通常需要标准化的测试方案来确保结果的有效性和可重复性。缺乏标准化方法可能会使产品获得监管批准的过程变得复杂，因为各机构可能会犹豫是否接受非标准化方法产生的资料。在缺乏标准化程序的情况下，不同的实验室在测试相同物质时可能会产生不同的结果，从而造成差异，从而引起行业之间的关注。

主要市场趋势：

• 1.先进的体外模型：紧密复製人类皮肤生理学的先进体外模型在皮肤毒性测试市场中越来越受到重视。这些模型准确地模拟皮肤屏障功能、细胞相互作用和复杂的生物过程，为物质如何与人体皮肤相互作用提供更可靠的见解。使用动物进行测试引起了道德问题，各行业越来越多地转向非动物方法。先进的体外模型透过消除动物测试的需要，同时仍提供具有科学意义的结果，提供了道德替代方案。监管机构正在认识到这些模型的价值，从而提高监管机构在满足安全评估要求方面的接受度和采用率。与动物测试相比，体外模型提供更快的结果，使各行业能够简化测试流程并缩短上市时间。它们同时测试多种物质的能力提高了效率，使它们对寻求准确和高效毒性评估的行业具有吸引力。
• 2.高通量筛选（HTS）：高通量筛选能够同时测试多种化合物，在皮肤毒性测试市场中越来越受欢迎。 HTS 在产品週转率高的行业中尤其有价值，因为它可以加快测试过程、缩短新产品的上市时间并优化资源利用率。传统的毒性测试方法既耗时又昂贵，这使得 HTS 成为具有成本效益的测试的有吸引力的选择。 HTS 快速产生大量资料，提供对潜在毒性的全面洞察并增强分析深度。它可以及早发现毒性问题，降低产品上市后昂贵召回或安全问题的风险。 HTS 可以涵盖广泛的毒性终点，包括皮肤刺激和致敏，这对于寻求全面安全评估的行业很有价值。

细分洞见：

• 1.测试方法类型见解：体外测试预计在整个预测期内将大幅市场成长。体外模型在结构和功能方面非常模仿人类皮肤，从而可以更准确地进行毒性评估。体外方法的采用显着减少了对传统动物测试的依赖，符合伦理考虑以及科学研究中尽量减少动物使用的更广泛趋势。世界各地的监管机构越来越认识到体外测试方法、简化审批流程和促进市场准入的价值。与动物测试相比，基于体外的测试方法通常可以提供更快的结果，从而可以在产品开发中更快地做出决策。
• 2.最终用途洞察：化妆品和个人护理产品产业一直是市场的主导力量。该行业对安全的承诺正在推动皮肤毒性测试市场的扩大。投资这些测试方法的公司有助于这种成长并从中受益。该行业的创新动力促进了皮肤毒性测试方法的研究和开发，从而推动了更先进、更准确的测试技术的发展。优先考虑严格的皮肤毒性测试的公司可以建立植根于安全性和透明度的强大品牌声誉，从而培养消费者的忠诚度和信任。

区域见解：

北美，特别是美国和加拿大，在 2022 年占据市场主导地位。该地区拥有强大的研究基础设施，促进创新皮肤毒性测试方法的开发和验证。北美的主要製药和化妆品行业推动了对彻底皮肤毒性测试的需求，因为他们优先考虑安全评估以满足监管要求和消费者期望。这些产业的存在推动了先进技术的采用，北美的公司和机构在研发方面投入大量资金。这项投资支持尖端皮肤毒性测试方法的创建和验证。资源和资金的可用性进一步促进了该地区新技术的发展和采用。北美化妆品、药品和化学品等行业的竞争本质促使公司采用创新方法，包括先进的皮肤毒性测试方法，以确保产品的安全性和功效。该地区还受益于学术机构、研究组织和行业参与者之间的合作网络，促进知识共享、研究伙伴关係和标准化测试方法的发展。

目录

第 1 章：产品概述

• 市场定义
• 市场范围
  • 涵盖的市场
  • 考虑学习的年份
  • 主要市场区隔

第 2 章：研究方法

• 研究目的
• 基线方法
• 主要产业伙伴
• 主要协会和二手资料来源
• 预测方法
• 数据三角测量与验证
• 假设和限制

第 3 章：执行摘要

• 市场概况
• 主要市场细分概述
• 主要市场参与者概述
• 重点地区/国家概况
• 市场驱动因素、挑战、趋势概述

第 4 章：客户之声

第 5 章：全球皮肤毒性​​测试市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依测试类型（皮肤刺激测试、皮肤致敏测试）
  • 依测试方法类型（体内测试（基于动物的测试）和体外测试（基于细胞或基于组织的测试）
  • 按最终用户（製药业、化妆品和个人护理产品行业、化学工业及其他）
  • 按地区（北美、欧洲、亚太地区、南美、中东和非洲）
  • 按公司划分 (2022)
• 市场地图
  • 按测试类型
  • 按测试方法类型
  • 按最终用户
  • 按地区

第 6 章：北美皮肤毒性测试市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依测试类型（皮肤刺激测试、皮肤致敏测试）
  • 依测试方法类型（体内测试（基于动物的测试）和体外测试（基于细胞或基于组织的测试）
  • 按最终用户（製药业、化妆品和个人护理产品行业、化学工业及其他）
  • 按国家/地区
• 北美：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第 7 章：欧洲皮肤毒性测试市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依测试类型（皮肤刺激测试、皮肤致敏测试）
  • 依测试方法类型（体内测试（基于动物的测试）和体外测试（基于细胞或基于组织的测试）
  • 按最终用户（製药业、化妆品和个人护理产品行业、化学工业及其他）
  • 按国家/地区
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 义大利
  • 西班牙

第 8 章：亚太地区皮肤毒性测试市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依测试类型（皮肤刺激测试、皮肤致敏测试）
  • 依测试方法类型（体内测试（基于动物的测试）和体外测试（基于细胞或基于组织的测试）
  • 按最终用户（製药业、化妆品和个人护理产品行业、化学工业及其他）
  • 按国家/地区
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第 9 章：南美洲皮肤毒性测试市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依测试类型（皮肤刺激测试、皮肤致敏测试）
  • 依测试方法类型（体内测试（基于动物的测试）和体外测试（基于细胞或基于组织的测试）
  • 按最终用户（製药业、化妆品和个人护理产品行业、化学工业及其他）
  • 按国家/地区
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第 10 章：中东和非洲皮肤毒性测试市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依测试类型（皮肤刺激测试、皮肤致敏测试）
  • 依测试方法类型（体内测试（基于动物的测试）和体外测试（基于细胞或基于组织的测试）
  • 按最终用户（製药业、化妆品和个人护理产品行业、化学工业及其他）
  • 按国家/地区
• MEA：国家分析
  • 南非皮肤毒性测试
  • 沙乌地阿拉伯皮肤毒性测试
  • 阿联酋皮肤毒性测试

第 11 章：市场动态

• 司机
• 挑战

第 12 章：市场趋势与发展

• 近期发展
• 併购
• 产品发布

第 13 章：全球皮肤毒性​​测试市场：SWOT 分析

第 14 章：波特的五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 客户的力量
• 替代产品的威胁

第15章：竞争格局

• 商业概览
• 产品供应
• 最近的发展
• 财务（据报导）
• 主要人员
• SWOT分析
  • SGS SA.
  • Covance, Inc
  • Bio-Rad Laboratories Inc.
  • Qiagen NV
  • GE Healthcare
  • Eurofins Scientific Inc
  • Merck KgaA
  • Thermo Fisher Scientific, Inc.
  • Charles River Laboratories International, Inc.
  • Catalent, Inc.

第 16 章：策略建议

The Global Dermal Toxicity Testing Market achieved a valuation of USD 1.81 Billion in 2022, and it is poised for robust growth in the forecast period, with a projected Compound Annual Growth Rate (CAGR) of 8.17% and is expected to reach USD 2.88 Billion by 2028. Dermal toxicity testing is a comprehensive procedure aimed at evaluating the adverse effects of substances on human skin. This process involves subjecting test substances to various protocols, ranging from traditional animal-based methods to innovative in vitro models that replicate human skin characteristics. Its primary objective is to identify any irritations, allergic reactions, sensitizations, or systemic toxicities that might arise from dermal exposure. The field of dermal toxicity testing has witnessed significant progress, transitioning from reliance on animal testing to more advanced and humane methods. In vitro models, 3D skin equivalents, and microfluidic platforms are revolutionizing the accuracy and efficiency of testing.

Key Market Drivers:

• 1. Industry-Specific Demands: Industry-specific demands have a significant impact on influencing the growth of the global dermal toxicity testing market. Dermal toxicity testing is crucial for product safety evaluation, particularly in industries such as cosmetics, pharmaceuticals, chemicals, and consumer goods. Different industries adhere to distinct regulations and guidelines governing product safety and testing. For example, the cosmetics industry must comply with regulations set by authorities like the U.S. FDA or the European Medicines Agency (EMA). These regulations often mandate thorough dermal toxicity testing to ensure ingredient safety in products. As regulatory requirements evolve, industries are compelled to adopt advanced testing methods, driving market growth. The cosmetics industry places high importance on dermal toxicity testing to ensure that skincare products, makeup, and personal care items do not cause adverse skin reactions. With increasing consumer demand for natural and organic products, the need for thorough testing to verify product safety has grown, fueling demand for innovative dermal toxicity testing methods. In the pharmaceutical sector, dermal toxicity testing is essential for assessing the safety of transdermal drug delivery systems, such as patches and creams. As pharmaceutical companies develop new drugs and delivery mechanisms, they require advanced testing methodologies to gain insights into how these substances interact with the skin, contributing to market growth. Industries dealing with chemicals, including industrial, agricultural, and household chemicals, must ensure the safety of their products to protect workers and consumers. Dermal toxicity testing is crucial in determining potential risks associated with skin exposure. As awareness of workplace safety and consumer health increases, companies in these sectors are likely to invest in more comprehensive testing methods, contributing to market growth.

Market Overview
Forecast Period	2024-2028
Market Size 2022	USD 1.81 Billion
Market Size 2028	USD 2.88 Billion
CAGR 2023-2028	8.17%
Fastest Growing Segment	Cosmetic & Personal Care
Largest Market	North America

• 2. Transition to Non-Animal Testing Methods: The shift towards non-animal testing methods significantly influences the growth of the global dermal toxicity testing market. Concerns about animal welfare, regulatory changes, and technological advancements are driving the adoption of alternative testing methods, reshaping the market's growth trajectory. Many regulatory bodies worldwide are increasingly advocating for and even mandating the use of non-animal testing methods in safety assessments. For example, the European Union's REACH (Registration, Evaluation, Authorization, and Restriction of Chemicals) regulation promotes alternative methods to animal testing for chemical safety evaluations. Regulatory authorities recognizing and endorsing non-animal methods motivate companies to adopt these methods to remain compliant, leading to market growth. The use of animals for testing raises ethical issues and can negatively impact a company's reputation. As public awareness of animal welfare grows, consumers and stakeholders may favor companies that employ cruelty-free testing methods, potentially boosting market growth. Non-animal testing methods, such as in vitro techniques, reconstructed human skin models, and computational modeling, have improved in accuracy and reliability, making them viable alternatives to traditional animal testing. As the scientific community develops and validates these methods, industries seeking more predictive and efficient testing are inclined to adopt them, contributing to market expansion. The shift toward non-animal testing methods encourages research and innovation in the field of toxicology, including the development of novel techniques and improved models. Industries that prioritize innovation and staying at the forefront of scientific advancements are likely to invest in these methods, fostering market growth.

• 3. Technological Innovations: Technological innovations play a pivotal role in influencing the growth of the global dermal toxicity testing market. As advancements in technology offer more accurate, efficient, and cost-effective testing methods, industries and regulatory bodies are increasingly adopting these innovations to ensure product safety. Technological advancements have led to the development of sophisticated in vitro testing methods using human-derived cells, tissues, and 3D models that accurately simulate skin reactions. In vitro testing offers a more relevant and reliable representation of human responses compared to traditional animal testing, contributing to its adoption by industries seeking accurate toxicity assessments. Microfluidics and organ-on-a-chip technologies enable the creation of miniaturized devices that mimic the structure and function of human organs, including the skin. These models provide a controlled environment to study cellular responses to substances, offer real-time insights into toxicity, and simulate substance-skin interactions, aiding hazard identification and market growth. High-throughput screening (HTS) technologies allow for the rapid testing of numerous substances simultaneously, accelerating the screening process and enabling early identification of potential hazards. Industries can use HTS to reduce costs and time-to-market, contributing to market expansion. Computational modeling and artificial intelligence (AI) techniques enable the prediction of dermal toxicity based on molecular structures and interactions, enhancing predictive capabilities and reducing the need for extensive lab testing, fostering market growth.

• 4. Public Awareness and Brand Reputation: Public awareness and brand reputation exert significant influence on the growth of the global dermal toxicity testing market. As consumers become increasingly conscious of product safety and ethical considerations, and as brands strive to maintain positive reputations, the demand for comprehensive dermal toxicity testing rises. In today's socially conscious world, consumers are increasingly concerned about ethical practices, including animal welfare and environmental impact. Brands that prioritize non-animal testing methods and demonstrate a commitment to ethical product development are likely to resonate with these consumers, driving demand for comprehensive dermal toxicity testing. Public awareness of potential health risks associated with products has led consumers to demand safer and more transparent formulations. Brands that conduct thorough dermal toxicity testing to ensure product safety can build trust with consumers. By addressing consumer safety concerns through rigorous testing and accurate labeling, brands can enhance their reputation and foster customer loyalty.

Key Market Challenges:

• 1. Validation of Alternative Methods: The validation of alternative methods can pose challenges and potentially hinder the growth of the global dermal toxicity testing market. While alternative methods are sought after due to their ethical considerations and scientific advancements, their validation process can be complex and time-consuming. The validation of alternative methods requires extensive research, data collection, and comparison to established reference methods, often including animal testing benchmarks. This process can be time-consuming and resource-intensive, slowing down the adoption of these methods and potentially hindering market growth.

• 2. Standardization Issues: The lack of standardized protocols in dermal toxicity testing can lead to inconsistent and variable test results, making it difficult to compare findings between different studies or laboratories. Such inconsistencies can undermine confidence in the reliability of test methods and hinder market growth. Regulatory agencies often require standardized testing protocols to ensure the validity and reproducibility of results. The absence of standardized methods can complicate the process of obtaining regulatory approvals for products, as agencies might be hesitant to accept data generated from non-standardized approaches. In the absence of standardized procedures, different laboratories might produce different results when testing the same substance, causing variability that can raise concerns among industries.

Key Market Trends:

• 1. Advanced In Vitro Models: Advanced in vitro models that closely replicate human skin physiology are gaining prominence in the dermal toxicity testing market. These models accurately simulate skin barrier function, cellular interactions, and complex biological processes, providing more reliable insights into how substances interact with human skin. The use of animals for testing raises ethical concerns, and industries are increasingly turning to non-animal methods. Advanced in vitro models offer an ethical alternative by eliminating the need for animal testing while still providing scientifically meaningful results. Regulatory bodies are recognizing the value of these models, leading to increased regulatory acceptance and adoption in fulfilling safety assessment requirements. In vitro models offer quicker results compared to animal testing, allowing industries to streamline their testing processes and reduce time-to-market. Their ability to test multiple substances simultaneously enhances efficiency, making them attractive to industries seeking accurate and efficient toxicity assessments.

• 2. High-Throughput Screening (HTS): High-throughput screening, which enables the simultaneous testing of multiple compounds, is gaining traction in the dermal toxicity testing market. HTS is particularly valuable in industries with high product turnover rates, as it accelerates the testing process, reduces time-to-market for new products, and optimizes resource utilization. Traditional toxicity testing methods can be time-consuming and expensive, making HTS an appealing option for cost-effective testing. HTS generates a large amount of data quickly, providing comprehensive insights into potential toxicity and enhancing the depth of analysis. It allows early detection of toxicity issues, reducing the risk of costly recalls or safety problems after a product's launch. HTS can encompass a wide range of toxicity endpoints, including skin irritation and sensitization, making it valuable for industries seeking comprehensive safety evaluations.

Segmental Insights:

• 1. Testing Method Type Insights: In Vitro Testing is expected to witness substantial market growth throughout the forecast period. In vitro models closely mimic human skin in terms of structure and function, resulting in more accurate toxicity assessments. The adoption of in vitro methods significantly reduces the reliance on traditional animal testing, aligning with ethical considerations and the broader trend of minimizing animal usage in scientific research. Regulatory agencies worldwide are increasingly acknowledging the value of in vitro testing methods, streamlining approval processes and facilitating market access. In vitro-based testing methods often offer faster results compared to animal testing, allowing for quicker decision-making in product development.

• 2. End Use Insights: The Cosmetics and personal care products industry segment has been the dominant force in the market. The industry's commitment to safety is driving the expansion of the dermal toxicity testing market. Companies investing in these testing methodologies contribute to and benefit from this growth. The industry's drive for innovation fosters research and development in dermal toxicity testing methods, leading to the evolution of more advanced and accurate testing technologies. Companies that prioritize rigorous dermal toxicity testing can build a strong brand reputation rooted in safety and transparency, fostering consumer loyalty and trust.

Regional Insights:

North America, specifically the United States and Canada, dominated the market in 2022. The region boasts robust research infrastructure, facilitating the development and validation of innovative dermal toxicity testing methods. Major pharmaceutical and cosmetics industries in North America drive the demand for thorough dermal toxicity testing, as they prioritize safety assessments to meet regulatory requirements and consumer expectations. The presence of these industries fuels the adoption of advanced technologies, and companies and institutions in North America invest heavily in research and development. This investment supports the creation and validation of cutting-edge dermal toxicity testing methods. The availability of resources and funding further facilitates the growth and adoption of new technologies in the region. The competitive nature of industries like cosmetics, pharmaceuticals, and chemicals in North America drives companies to adopt innovative approaches, including advanced dermal toxicity testing methods, to ensure product safety and efficacy. The region also benefits from collaborative networks between academic institutions, research organizations, and industry players, facilitating knowledge sharing, research partnerships, and the development of standardized testing methods.

Key Market Players

• SGS S.A..
• Covance, Inc
• Bio-Rad Laboratories Inc.
• Qiagen N.V.
• GE Healthcare
• Eurofins Scientific Inc
• Merck KgaA
• Thermo Fisher Scientific, Inc.
• Charles River Laboratories International, Inc.
• Catalent, Inc.

Report Scope:

In this report, the Global Dermal Toxicity Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Dermal Toxicity Testing Market, By Test Type:

• Skin Irritation Tests
• Skin Sensitization Tests

Dermal Toxicity Testing Market, By Testing Method Type:

• In Vivo Testing (Animal-Based Tests)
• In Vitro Testing (Cell-Based or Tissue-Based Tests)

Dermal Toxicity Testing Market, By End User:

• Pharmaceuticals industries
• Cosmetics and personal care products industry
• Chemical Industry
• Other

Dermal Toxicity Testing Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia-Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• Kuwait
• Turkey
• Egypt

Competitive Landscape

• Company Profiles: Detailed analysis of the major companies present in the Global Dermal Toxicity Testing Market.

Available Customizations:

• Global Dermal Toxicity Testing market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Dermal Toxicity Testing Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Test Type (Skin Irritation Tests, Skin Sensitization Tests)
  • 5.2.2. By Testing Method Type (In Vivo Testing (Animal-Based Tests) and In Vitro Testing (Cell-Based or Tissue-Based Tests)
  • 5.2.3. By End User (Pharmaceuticals industries, Cosmetics and personal care products industry, Chemical Industry and Other)
  • 5.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
  • 5.2.5. By Company (2022)
• 5.3. Market Map
  • 5.3.1 By Test Type
  • 5.3.2 By Testing Method Type
  • 5.3.3 By End User
  • 5.3.4 By Region

6. North America Dermal Toxicity Testing Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Test Type (Skin Irritation Tests, Skin Sensitization Tests)
  • 6.2.2. By Testing Method Type (In Vivo Testing (Animal-Based Tests) and In Vitro Testing (Cell-Based or Tissue-Based Tests)
  • 6.2.3. By End User (Pharmaceuticals industries, Cosmetics and personal care products industry, Chemical Industry and Other)
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Dermal Toxicity Testing Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Test Type
      • 6.3.1.2.2. By Testing Method Type
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Dermal Toxicity Testing Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Test Type
      • 6.3.2.2.2. By Testing Method Type
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Dermal Toxicity Testing Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Test Type
      • 6.3.3.2.2. By Testing Method Type
      • 6.3.3.2.3. By End User

7. Europe Dermal Toxicity Testing Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Test Type (Skin Irritation Tests, Skin Sensitization Tests)
  • 7.2.2. By Testing Method Type (In Vivo Testing (Animal-Based Tests) and In Vitro Testing (Cell-Based or Tissue-Based Tests)
  • 7.2.3. By End User (Pharmaceuticals industries, Cosmetics and personal care products industry, Chemical Industry and Other)
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Dermal Toxicity Testing Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Test Type
      • 7.3.1.2.2. By Testing Method Type
      • 7.3.1.2.3. By End User
  • 7.3.2. Germany Dermal Toxicity Testing Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Test Type
      • 7.3.2.2.2. By Testing Method Type
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Dermal Toxicity Testing Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Test Type
      • 7.3.3.2.2. By Testing Method Type
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Dermal Toxicity Testing Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Test Type
      • 7.3.4.2.2. By Testing Method Type
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Dermal Toxicity Testing Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Test Type
      • 7.3.5.2.2. By Testing Method Type
      • 7.3.5.2.3. By End User

8. Asia-Pacific Dermal Toxicity Testing Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Test Type (Skin Irritation Tests, Skin Sensitization Tests)
  • 8.2.2. By Testing Method Type (In Vivo Testing (Animal-Based Tests) and In Vitro Testing (Cell-Based or Tissue-Based Tests)
  • 8.2.3. By End User (Pharmaceuticals industries, Cosmetics and personal care products industry, Chemical Industry and Other)
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Dermal Toxicity Testing Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Test Type
      • 8.3.1.2.2. By Testing Method Type
      • 8.3.1.2.3. By End User
  • 8.3.2. India Dermal Toxicity Testing Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Test Type
      • 8.3.2.2.2. By Testing Method Type
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Dermal Toxicity Testing Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Test Type
      • 8.3.3.2.2. By Testing Method Type
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Dermal Toxicity Testing Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Test Type
      • 8.3.4.2.2. By Testing Method Type
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Dermal Toxicity Testing Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Test Type
      • 8.3.5.2.2. By Testing Method Type
      • 8.3.5.2.3. By End User

9. South America Dermal Toxicity Testing Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Test Type (Skin Irritation Tests, Skin Sensitization Tests)
  • 9.2.2. By Testing Method Type (In Vivo Testing (Animal-Based Tests) and In Vitro Testing (Cell-Based or Tissue-Based Tests)
  • 9.2.3. By End User (Pharmaceuticals industries, Cosmetics and personal care products industry, Chemical Industry and Other)
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Dermal Toxicity Testing Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Test Type
      • 9.3.1.2.2. By Testing Method Type
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina Dermal Toxicity Testing Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Test Type
      • 9.3.2.2.3. By Testing Method Type
      • 9.3.2.2.4. By End User
  • 9.3.3. Colombia Dermal Toxicity Testing Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Test Type
      • 9.3.3.2.2. By Testing Method Type
      • 9.3.3.2.3. By End User

10. Middle East and Africa Dermal Toxicity Testing Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Test Type (Skin Irritation Tests, Skin Sensitization Tests)
  • 10.2.2. By Testing Method Type (In Vivo Testing (Animal-Based Tests) and In Vitro Testing (Cell-Based or Tissue-Based Tests)
  • 10.2.3. By End User (Pharmaceuticals industries, Cosmetics and personal care products industry, Chemical Industry and Other)
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Dermal Toxicity Testing Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Test Type
      • 10.3.1.2.2. By Testing Method Type
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia Dermal Toxicity Testing Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Test Type
      • 10.3.2.2.2. By Testing Method Type
      • 10.3.2.2.3. By End User
  • 10.3.3. UAE Dermal Toxicity Testing Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Test Type
      • 10.3.3.2.2. By Testing Method Type
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global Dermal Toxicity Testing Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Business Overview
• 15.2. Product Offerings
• 15.3. Recent Developments
• 15.4. Financials (As Reported)
• 15.5. Key Personnel
• 15.6. SWOT Analysis
  • 15.6.1 SGS S.A..
  • 15.6.2 Covance, Inc
  • 15.6.3 Bio-Rad Laboratories Inc.
  • 15.6.4 Qiagen N.V.
  • 15.6.5 GE Healthcare
  • 15.6.6 Eurofins Scientific Inc
  • 15.6.7 Merck KgaA
  • 15.6.8 Thermo Fisher Scientific, Inc.
  • 15.6.9 Charles River Laboratories International, Inc.
  • 15.6.10 Catalent, Inc.

16. Strategic Recommendations